Agios Pharma (AGIO) Tops Q1 EPS by 15c, Beat on Revenues

Agios Pharma (NASDAQ: AGIO) reported Q1 EPS of ($1.56), $0.15 better than the analyst estimate of ($1.71). Revenue for the quarter came in at $10.5 million versus the consensus estimate of $8.07 million.

For earnings history and earnings-related data on Agios Pharma (AGIO) click here.

You May Also Be Interested In

• Ambarella (AMBA) Tops Q2 EPS by 1c; offers guidance
• Intel (INTC) PT Lowered to $92 at Mizuho
• Mama's Creations, Inc. (MAMA) Tops Q3 EPS by 1c